Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate

Morie A. Gertz, M. Q. Lacy, A. Dispenzieri, S. M. Ansell, M. A. Elliott, D. A. Gastineau, D. J. Inwards, I. N.M. Micallef, L. F. Porrata, A. Tefferi, M. R. Litzow

Research output: Contribution to journal › Review article › peer-review

99 Scopus citations

Fingerprint

Dive into the research topics of 'Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate'. Together they form a unique fingerprint.

Medicine & Life Sciences